[Guidelines for treatment of non-neurological urinary incontinence in women using periurethral injections].
Currently there are no data reported in the literature supporting the recommendation for peri-urethral injections in first-line treatment. However, some authors emphasize that periurethral injection techniques can be used because of their good risk/benefit ratio in patients who are fragile, those who have already undergone surgery, and those who do not wish to have surgery. This option should be chosen based on efficacy, safety, and the patient's wishes. The product used should remain based on safety, ease of use, price, and the urologist's preferences. In all cases, efficacy decreases with time and repeated injections are often necessary to maintain a satisfactory result. The injectables are a possible first-line choice in very elderly patients and in those who do not wish to undergo surgery. After failure of surgical treatment and/or if there is sphincter deficiency, peri-urethral injections can be an alternative to a new surgery, but one must be aware that the results are clearly inferior to balloons or the sphincter. In cases where the urethra is attached due to previous interventions, peri-urethral injection is not indicated.
Cortesse
A
A
Service d'Urologie, CHU Saint-Louis, 1, avenue Claude Vellefaux 75010 Paris, France. ariane.cortesse@sls.aphp.fr
D000180:Acrylic Resins / Q000008:administration & dosage; D001672:Biocompatible Materials / Q000008:administration & dosage; D003094:Collagen / Q000008:administration & dosage; D004129:Dimethylpolysiloxanes / Q000008:administration & dosage; D005260:Female; D006801:Humans; D020100:Hydrogels / Q000008:administration & dosage; D007267:Injections; D014549:Urinary Incontinence / Q000628:therapy*
D000180:Acrylic Resins; D001672:Biocompatible Materials; C528271:Bulkamid; D004129:Dimethylpolysiloxanes; D020100:Hydrogels; C048470:glutaraldehyde-cross-linked collagen; C013830:baysilon; D003094:Collagen